FDA Recalls Contrave Tablets Due to Punctured Bottle Complaints
Orexigen Therapeutics is recalling 95,296 bottles of Contrave extended-release tablets due to customer complaints of punctures in the bottles.
- Product
- CONTRAVE — CONTRAVE (NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide